Over the years, this group has developed several projects funded by Europe, the Spanish and Galician governments, foundations and also by private enterprises. Due to its wide network within the health sector and the international research community the group has held several international and national collaborations.


Currently the group is focused on different research lines:

  • NanoMedicine: Biocompatibility: toxicity and immune response to nanoparticles.
  • Vaccines: Immune response to several prototypes using animal models.
  • Immunotherapy: Development of human Monoclonal antibodies directed against human leukemia and inflammatory cells with potential in human immunotherapy.
  • Animal models of fibrosis and autoimmune diseases.
  • Generation of monoclonal antibodies with different applications:

- Marine field: identification of mussels, algae and marine toxins.

- Development of biosensors.

- Modelling the immune response.